Baker McKenzie Acts as Global Counsel to Medtronic plc on the Carve-out and Spin-off of their Diabetes business, MiniMed Group, Inc.
Baker McKenzie served as global counsel to Medtronic plc with the spin-off and carve-out of their diabetes division, MiniMed Group, Inc. MiniMed was valued at more than USD 5.3 billion at the end of its first day of trading on the Nasdaq on March 6, 2026.